
"Sector" = median of Healthcare across 84 companies
Stryker Corporation is a global leader in medical technology, specializing in orthopedic implants, surgical equipment, and neurotechnology. Founded in 1941 and headquartered in Kalamazoo, Michigan, the company operates through three segments: Orthopaedics and Spine, MedSurg, and Neurotechnology. Stryker's products include joint replacement implants, trauma and extremities devices, surgical power tools, endoscopy systems, and hospital beds. The company serves hospitals, surgical centers, and healthcare providers worldwide, with a strong presence in the US, Europe, and Asia-Pacific.
Stryker generates revenue primarily from the sale of medical devices and equipment. The Orthopaedics and Spine segment (largest contributor) offers hip and knee implants, spine implants, and trauma products. The MedSurg segment provides surgical instruments, patient handling equipment, and emergency medical products. Neurotechnology includes cranial and spinal implants, minimally invasive surgical systems, and neurovascular devices. The company also earns recurring revenue from consumables and service contracts. In the latest fiscal year, Stryker reported $22.2 billion in total revenue, with about 70% from the US and 30% from international markets.
Stryker competes in the highly regulated medical devices industry, facing rivals like Medtronic, Johnson & Johnson (DePuy Synthes), and Zimmer Biomet. The company holds a strong position in orthopedics, particularly in joint replacement and trauma, and is a leader in surgical equipment. Stryker's competitive advantages include a broad product portfolio, strong R&D pipeline (e.g., Mako robotic-arm assisted surgery), and a well-established distribution network. The industry is driven by aging populations, rising healthcare spending, and technological innovation, but faces pricing pressure and regulatory hurdles.
Stryker's primary customers are hospitals, ambulatory surgery centers, and healthcare institutions. The company's products are used by orthopedic surgeons, neurosurgeons, and other medical specialists. Geographically, the US is the largest market, accounting for roughly 70% of sales. International markets include Europe (especially Germany, France, and the UK), Asia-Pacific (Japan, Australia, China), and emerging markets. Stryker's target audience is healthcare providers seeking advanced, reliable medical technologies to improve patient outcomes and operational efficiency.
An auto-generated descriptive profile based on company data, for informational purposes only.
Stryker Corporation (SYK) shares declined 3.42% to close at $319.87, pressured by a sector-wide selloff in medical device stocks following J&J's Q2 report and cautious guidance. Despite J&J beating estimates, its stock fell, raising concerns about industry growth. The weakness spread to peers like Intuitive Surgical and Abbott, dragging down SYK. No company-specific news drove the move.
Latest saved period: March 2026 · 2026-03-31
Cash dividends by ex-date, not an investment recommendation.
| Ex-date | Amount | Payment date | Period |
|---|---|---|---|
| Mar 31, 2026 | $0.88 | Apr 30, 2026 | Quarterly |
| Dec 31, 2025 | $0.88 | Jan 30, 2026 | Quarterly |
| Sep 30, 2025 | $0.84 | Oct 31, 2025 | Quarterly |
| Jun 30, 2025 | $0.84 | Jul 31, 2025 | Quarterly |
| Mar 31, 2025 | $0.84 | Apr 30, 2025 | Quarterly |
| Dec 31, 2024 | $0.84 | Jan 31, 2025 | Quarterly |
| Sep 30, 2024 | $0.80 | Oct 31, 2024 | Quarterly |
| Jun 28, 2024 | $0.80 | Jul 31, 2024 | Quarterly |
| Mar 27, 2024 | $0.80 | Apr 30, 2024 | Quarterly |
| Dec 28, 2023 | $0.80 | Jan 31, 2024 | Quarterly |
| Sep 28, 2023 | $0.75 | Oct 31, 2023 | Quarterly |
| Jun 29, 2023 | $0.75 | Jul 31, 2023 | Quarterly |
| Mar 30, 2023 | $0.75 | Apr 28, 2023 | Quarterly |
| Dec 29, 2022 | $0.75 | Jan 31, 2023 | Quarterly |
| Sep 29, 2022 | $0.70 | Oct 31, 2022 | Quarterly |
| Jun 29, 2022 | $0.70 | Jul 29, 2022 | Quarterly |
| Mar 30, 2022 | $0.70 | Apr 29, 2022 | Quarterly |
| Dec 30, 2021 | $0.70 | Jan 31, 2022 | Quarterly |
| Sep 29, 2021 | $0.63 | Oct 29, 2021 | Quarterly |
| Jun 29, 2021 | $0.63 | Jul 30, 2021 | Quarterly |
| Mar 30, 2021 | $0.63 | Apr 30, 2021 | Quarterly |
| Dec 30, 2020 | $0.63 | Jan 29, 2021 | Quarterly |
| Sep 29, 2020 | $0.58 | Oct 30, 2020 | Quarterly |
| Jun 29, 2020 | $0.58 | Jul 31, 2020 | Quarterly |
Wrqti brings Stryker Corporation data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Companies in the Healthcare sector you can compare with Stryker Corporation:
When available, the page shows quarterly and annual statements plus ratios such as PE, price to book, profit margin, and free cash flow. Latest financial period shown: March 2026.
Wrqti content depends on available data and third-party sources and may include delays or errors. Review official company filings and consult a licensed financial advisor before making investment decisions. Read the data methodology.